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BACKGROUND፡ There are few data concerning the prevalence 
and predictors of musculoskeletal pain among adults with type 2 
diabetes in population with low-risk of obesity. Our objective was 
to describe the point prevalence and factors associated with 
increased risk of musculoskeletal pain in this population. 
METHODS: A cross-sectional data of 200 adults with type 2 
diabetes, aged ≥ 18 years who were attending two tertiary 
hospitals were examined. Musculoskeletal pain and physical 
activity were collected with Nordic Musculoskeletal Questionnaire 
(NMQ) and International Physical Activity Questionnaire (IPAQ-
SF) respectively. We used logistic regression to examine the risks 
associated with musculoskeletal pain. 
RESULTS: The point prevalence of musculoskeletal pain was 
72.7% and similar between men (72.3%) and women (73.1%). In 
the last 7days, advancing age (odds ratio=1.09;95%CI:1.02-1.16) 
and comorbidity (odds ratio=3.0;95%CI:1.07-8.39) were risk 
factors associated with musculoskeletal pain. In the last 12 
months, only comorbidity (odds ratio=5.57;95%CI:1.62-19.17) 
was a risk factor for increasing musculoskeletal pain. However, a 
unit increase in physical activity level (odds 
ratio=0.06;95%CI:0.008-0.51) was associated with decreased odds 
of musculoskeletal pain. 
CONCLUSIONS: The prevalence of musculoskeletal pain was 
high and physical activity was associated with a decreased risk 
thereof. A further research should be evaluated on the influence 
of physical activity on musculoskeletal pain. 
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Type 2 diabetes mellitus is one of the leading causes of mortality 
globally (1), a development that has contributed to the socio-
economic burden and unfavourable economic indices in both 
developed and developing nations (2). People with type 2 diabetes 
have a higher prevalence of musculoskeletal pain and its 
manifestation in this population accounts for a marked increase in 
institutionalization and hospital visits (3). In two cross-sectional
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studies, the prevalence of musculoskeletal pain 
in adults above 18 years with type 2 diabetes 
ranged from 46.5% to 82% (4,5). The 
prevalence of musculoskeletal pain increases 
with age and is higher in women (6). The 
mechanism of musculoskeletal pain in adults 
with type 2 diabetes is less clear; however, 
several factors have been observed to exacerbate 
the propensity for musculoskeletal pain. These 
include neuropathy (7) vascular insufficiencies 
(8), vitamin D deficiency (9), decreased insulin-
like growth factors (IGF-1) (10), sedentary 
behaviours (11), reduced dietary intake (12) and 
obesity (13).  Musculoskeletal pain is associated 
with decreased physical function and quality of 
life (6). Therefore, improving the physical 
activity (PA) level of patients with type 2 
diabetes is crucial to promoting physical 
function and quality of life. Guidelines for 
physical activity in this population recommend 
moderate-intensity exercise of at least 150 
minutes per week. This threshold is associated 
with improved glycaemic control and insulin 
sensitivity (14). Apart from aerobic exercise, it 
has also been observed that resistance training 
reduces the prevalence of hyperglycaemia in 
patients with type 2 diabetes (14). 
However, there are concerns that inherited 
genetic susceptibility, behavioural risk variations 
(e.g. obesity and sedentary lifestyle), and ethnic 
differences are central to defective insulin 
secretion and insulin resistance (15). This 
phenomenon underscores the variations in 
vascular complications and risk factors 
associated with type 2 diabetes (16). For 
example, the effect of environmental factors 
(obesity) and difference in genetic origin are 
some of the reasons why the prevalence of type 
2 diabetes is low in African countries compared 
with Western countries (17). Consequently, 
there is a paucity of studies in African 
populations on the prevalence of 
musculoskeletal pain and its risk factors in 
populations with low risk of obesity.  Studies in 
African populations are thus needed. The aim of 
this study therefore was to determine the point 
prevalence of musculoskeletal pain and its risk 
factors in adults with type 2 diabetes in Northern 
Nigeria. We hypothesized that the prevalence of 
musculoskeletal pain in this setting will be lower 
than what was reported elsewhere.  
 
MATERIALS and METHODS 
 
This was a cross-sectional hospital-based study 
was conducted on adults with type 2 diabetes, 
aged 18 or older who were attending the 
endocrinology clinic of two tertiary hospitals in 
Kano metropolis, Nigeria. We used the diabetes 
registers, which included information on 
diagnosis, co-existing conditions, treatment and 
demographic characteristics, to recruit 
participants into the study. The participants were 
recruited consecutively during routine treatment 
visits. However, patients diagnosed with type 2 
diabetes but either had a physical disability 
and/or a diabetic foot were excluded from the 
study.  
 
The sample size for this study was estimated 
using single proportion formula (18) taking 
previous prevalence of musculoskeletal pain in 
this population, 82.6% (5) and a precision error 
of 5%, we used a priori sample size parameters 
(Z = 1.96; P=0.826; d=0.05) to estimate an 
appropriate sample size of 220.  
 
Data collection, variables and sources of data: 
Data were collected between August 01 and 
November 31, 2017. Demographic variables 
obtained include age, gender, level of education, 
disease duration and co-existing conditions. 
Body weight and height were measured 
according to the standards of the International 
Society for the Advancement of 
Kinanthropometry (ISAK) (19). We collapsed 
both “Obesity” (BMI ≥ 30 kg/m2) and 
“Overweight” (BMI 25-29.99 kg/m2) into one 
category “Obesity” in order not to violate the 
assumptions of chi-square concerning the 
minimum expected cell frequency. Underweight 
was defined as BMI < 18.5 kg/m2 and “Normal” 
weight as BMI of 18.5-24.99 kg/m2. The 
Standardized Nordic Musculoskeletal 
Questionnaire (20) was used to assess the 
presence of musculoskeletal pain in nine major 
body regions (neck, shoulders, upper back, 
lower back, elbows, wrists, thighs, knees and 
ankles) in the 7 days (acute pain) and 12 months 
(chronic pain) before the study. The presence of 
musculoskeletal pain in at least one body region 
was categorized as (Yes pain: 1) and no pain in 
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any body region was categorized as 0 (No pain: 
0). The dichotomous variable (Yes pain: 1; No 
pain: 0) was used to estimate point prevalence of 
musculoskeletal pain in the last 12 months. The 
International Physical Activity Questionnaire-
short version (IPAQ-Short Form) (21) was used 
to assess the frequency, intensity, duration and 
type of seven-day recall of total physical 
activity. The total PA was defined as “Low PA” 
(< 3 MET, Metabolic Equivalent Task), 
“Moderate PA” (3-6 MET) and “Vigorous PA” 
(> 6 MET) (22). One MET is defined as the 
energy expended (or amount of oxygen 
consumed) at rest and is roughly equal to 3.5 ml 
of O2 per kilogram body weight multiplied by a 
minute in adults.  
 
Ethical approval: Ethical approval was 
obtained from the Aminu Kano Teaching 
Hospital Research Ethics Committee 
(AKTH/MAC/SUB/12A/P-3/VI/2110) and the 
ethical protocols of the Declaration of Helsinki 
(1967) including the ethical principles of 
informed consent, voluntary participation and 
withdrawal, privacy and confidentiality, were 
followed to ensure wellbeing, safety and 
protection of study participants (23). 
 
Data analysis and statistics: Descriptive 
statistical techniques in the form of tables, charts 
and percentages were used to present the 
prevalence and patterns of musculoskeletal pain 
in the last 12 months. Inferential statistics of 
Chi-square test (χ2) for independence (with 
Yates Continuity Correction) were used to 
determine the association between the presence 
of musculoskeletal pain (1= Yes; 0 =No pain) 
and participants’ characteristics (sex, age, 
education, presence of co-existing condition, 
BMI, and PA). Multivariate logistic regression 
(stepwise forward selection method) was used to 
determine the contribution of each of age, sex, 
education, co-morbidity, disease duration, body 
mass index and physical activity to the presence 
of musculoskeletal pain. Assumptions for 
logistic regression were checked for 
multicollinerity (Cook’s distance), model’s fit 
(Omnibus test; Hosmer and Lemeshow test), and 
potential outliers were checked. The data were 
analysed using the Statistical Package for Social 
Science (SPSS) version 22 and significance 




Characteristics of the study population: A 
total of 198 adults with type 2 diabetes, with a 
mean age of 48.3 years were examined (Table 
1). The majority of the participants were females 
(52.5%), had informal education (47%) and had 
comorbidity (40.9%). Their mean disease 
duration was 3.24 ± SD 2.78 years; mean BMI 
was 25.85 ± SD 4.09 kg/m2 and mean total 
physical activity was 6.81 ± 0.93 MET. Overall, 
42.9% had low physical activity. 
Prevalence and pattern of musculoskeletal 
pain: The overall prevalence of musculoskeletal 
pain was 72.7%, similar in men and women. 
(Figure 1). Prevalence of musculoskeletal pain 
increased with age, comorbidity, low education 
and sedentary behaviour (Figure 1). Most 
occurrences of musculoskeletal pain were in the 
upper extremities, in the head (59.3%), neck 
(59.3%) and shoulder (42.4%) (Figure 2). The 
prevalence of musculoskeletal pain was least in 
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Sex, n (%) 
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Comorbidity., n (%) 
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Figure 1: Prevalence of musculoskeletal pain in adults with type 2 diabetes according to gender, age, 
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Figure 2: Pattern of musculoskeletal pain in adults with type 2 diabetes in a low-risk obesity population. 
 
Risk factors for musculoskeletal pain: Chi-
square test (χ²) of independence indicated a 
significant association between musculoskeletal 
pain status and age [seven-day MSP: χ² (2) = 
30.70, p<0.001; 12-month MSP:χ² (2) = 11.91, 
p<0.05],  education [seven-day MSP:χ² (3) = 
48.71, p<0.001; 12-month MSP: χ² (2) = 30.34, 
p<0.001] and comorbidity status [seven-day 
MSP: χ² (1) = 30.75, p<0.001; 12-month:χ² (2) = 
15.40, p<0.001] (Table 2). Similarly, results 
suggested a significant association between 
musculoskeletal pain and physical activity status 
[seven-day MSP: χ² (2) = 32.07, p<0.001; 12-
month MSP: χ² (2) = 20.53, p<0.001]. 
In the last 7 days, logistic regression 
analysis showed that advancing age (odds 
ratio=1.09;95%CI:1.02-1.16) and comorbidity 
(odds ratio=3.0;95%CI:1.07-8.39) were risk 
factors associated with musculoskeletal pain, (χ² 
(9) = 38.66, p<0.001) (Table 3). The model 
explained 33% variance in the risk of 
musculoskeletal pain (Nagelkerke, R2) and was 
able to identify 68% cases accurately. The 
sensitivity and specificity of the model were 
71% and 65% respectively. The results showed 
that for every 1 unit increase in age and 
comorbidity status, the odds of occurrence of 
musculoskeletal pain in the last seven days 
increase by 1.09 and 3.00 times respectively. 
However, in the last 12 months, comorbidity and 
physical activity level had significant influence 
on musculoskeletal pain, (χ² (9) = 32.77, 
p<0.001), at 43% sensitivity and 86% 
specificity. The results showed that comorbidity 
increased the odds of musculoskeletal pain in the 
last 12 months by 6 times (OR = 5.57, p = 
0.006). However, adults with high physical 
activity level are 4% likely to develop 
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Table 2: Association of selected factors with musculoskeletal pain of adults with type 2 diabetes in low 
risk obesity populations. 
 
 
Characteristics 7-day musculoskeletal pain 12-month musculoskeletal pain 
 No Pain Pain χ² No Pain Pain χ² 
Gender, n (%) 
  Male 
  Female 
Age, n (%) 
  18-44y 
  45-64y 
  >64y 
Education, n (%) 
  Informal 
  Primary 
  Secondary 
  Tertiary 
Comorbidity, n (%) 
  No 
  Yes 
BMI, n (%) 
  Underweight 
  Normal 
  Overweight/obese 
Physical activity, n 
(%) 
  Low 
  Moderate 









































































































































**associations significant at p<0.001, *association significant at p<0.05 
 





7-day musculoskeletal pain1 12-month musculoskeletal pain2 














































1.Omnibus χ² (9) = 38.66, p<0.001, R2 = 24.6% (Cox & Snell), 32.8% (Nagelkerke) Overall = 67.9% (SEN = 
71.2%; specificity = 64.8%) 
2.Omnibus χ² (9) = 32.77, p<0.001, R2 = 21% (Cox & Snell), 29.1% (Nagelkerke) Overall = 71.2% (SEN = 42.6%; 
specificity = 85.9%) 
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This study found that the prevalence of 
musculoskeletal pain in adults with type 2 
diabetes in populations with low risk of obesity 
was (72.7%) and proportionately similar 
between males and females. A similar 
prevalence of musculoskeletal pain among 
adults with type 2 diabetes has been observed in 
Europe (6). However, in the present study, the 
prevalence of musculoskeletal pain reported in 
the primary weight-bearing joints (lower back, 
knee and hip) seems lower compared to Molsted 
et al. with a different study population (Danish). 
In comparison, Molsted et al. collected history 
of pain in the last 14 days compared to the 
commonly used Nordic Musculoskeletal 
Questionnaire, which requested history of pain 
in the last seven days and 12 months. In 
addition, Molsted et al. was conducted among 
the Danish populations with a high prevalence of 
obesity (24). The presence of obesity increased 
the risk of lower limb osteoarthritis (25). 
Furthermore, our study population consisted of 
Hausa-Fulani residents, who are known to have 
slimmer stature and lower BMI (26). It is likely 
that a high proportion of them would have lower 
BMI, and hence prevalence of musculoskeletal 
pain in the lower body regions may be expected 
to be lower. Intuitively, the lack of association 
of musculoskeletal pain with obesity in our 
study may be partly due to reduced statistical 
power, resulting from collapsing of ‘overweight’ 
and ‘obese’ items into one item. Collapsing 
items for statistical convenience has previously 
been reported to be associated with loss of 
statistical information (27).  
It has been observed that clustering of other 
components of metabolic syndromes (e.g. 
physical inactivity) increases the risk of 
diabetes-induced osteoarthritis (28). 
Furthermore, the lack of association thereof 
between obesity and increased prevalence of 
musculoskeletal pain appears not to be fixated 
on increased BMI; even adults with type 2 
diabetes and normal weight but sedentary 
lifestyle may also be at risk. Unfortunately, the 
risk of musculoskeletal complications for adults 
with type 2 diabetes and obese compared to 
adults with type 2 diabetes and normal weight 
but who were inactive was not investigated in 
this study. However, in this study, physical 
activity and high level of education were 
strongly associated with a decreased risk of 
prevalence of musculoskeletal pain in patients 
with type 2 diabetes. Like in previous studies, 
participants with higher educational levels had 
lower risk of type 2 diabetes mellitus (29). 
Regular and increasing physical activity improve 
glycaemic control and reduce peripheral 
resistance to insulin (30), which hitherto played 
a protective role in reducing the formation of 
advanced glycation end products, a precursor of 
musculoskeletal complications in patients with 
type 2 diabetes (31). In line with the 
recommendations of van Dijk and colleagues 
(14), overwhelming evidence in the literature 
shows that exercise interventions, which include 
aerobic exercise, resistance exercise, flexibility 
training and balance training improve insulin 
sensitivity, endothelial function and glucose 
homeostasis in patients with type 2 diabetes. 
Public health education on the importance of 
physical activity should be undertaken to 
mitigate the effect of AGEs in musculoskeletal 
complications in patients with type 2 diabetes 
(32). Based on the differential estimates of 
sensitivity and specificity for our logistic 
regression models, it may be easier to associate 
age and comorbidity to musculoskeletal pain in 
the last seven days in adults with type 2 
diabetes. However, poor sensitivity observed 
(43%) in participants who reported 
musculoskeletal pain in the last 12 months 
presents a difficult-to-diagnose condition in the 
long term. It is anticipated that sensitivity and 
specificity vary with disease spectrum and its 
prevalences (33,34). Overall, age and 
comorbidity may be more sensitive to acute 
musculoskeletal pain than a long-standing case 
of musculoskeletal pain in this population. 
Nevertheless, this study had several 
limitations. First, the study had no control group, 
hence attributable risk for musculoskeletal pain 
in this population cannot be determined. Second, 
since this was a hospital-based study of the 
prevalence of musculoskeletal pain in adults 
with type 2 diabetes receiving care at selected 
hospitals, the prevalence of musculoskeletal pain 
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in this population may be exaggerated by co-
existence of other diseases. Third, the study may 
have been underpowered to detect the influence 
of BMI in the logistic regression model because 
we collapsed ‘overweight’ and ‘obese’ into one 
item. In conclusion, our results show that 
musculoskeletal pain is highly prevalent in 
adults with type 2 diabetes in populations with 
low risk of obesity. However, the pattern of the 
prevalence is lower in the primary weight-
bearing joints. Advancing age together with 
comorbidity are associated with an increased 
risk of musculoskeletal pain in this population. 
The association of physical activity and tertiary 
educational level with the decreased odds of 
prevalence of musculoskeletal pain underscores 
the need to develop an evidence-based health 
education programme designed to promote 
physical activity in order to prevent and reduce 




• Prevalence of musculoskeletal pain in 
adults with type 2 diabetes in 
populations with low risk of obesity is 
high and similar between men and 
women. 
• Prevalence of musculoskeletal pain is 
higher in those who were older, having 
other medical conditions and sedentary. 
• Advancing age and comorbidity are risk 
factors associated with musculoskeletal 
pain in adults with type 2 diabetes from 
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